Diagnosis and treatment of Alzheimer disease and related disorders: consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society

Article Abstract:

Alzheimer's disease (AD) is probably underdiagnosed because physicians do not recognize early warning signs and family members don't report them. AD is the most common form of dementia and is characterized by a progressive decline in cognitive function. It can be diagnosed by a general medical and psychiatric assessment. The only drugs approved to enhance cognition are the cholinesterase inhibitors tacrine and donepezil. NSAIDS, estrogen and Ginkgo biloba are being evaluated. Antidepressants may also be needed and selective serotonin reuptake inhibitors such as fluoxetine are effective with few side effects.

Alzheimer's disease

---

Risk of death with atypical antipsychotic drug treatment for dementia

Article Abstract:

The evidence for increased mortality from atypical antipsychotic drug treatment for people with dementia is assessed. Atypical antipsychotic drugs may be associated with a small increased risk for death compared with placebo.

United States, Risk factors, Drug therapy, Dosage and administration, Antipsychotic drugs, Antipsychotic agents

---

Similar abstracts:

• Abstracts: Strategize to decrease liability premiums. True value: Whether buying or selling a practice, there are ways to ensure that the transaction comes at the right price for both parties
• Abstracts: Hypercalcemia and ectopic secretion of parathyroid hormone by an ovarian carcinoma with rearrangement of the gene for parathyroid hormone
• Abstracts: Lymphangiogenesis in development and human disease. Therapeutic differentiation and maturation of lymphatic vessels after node dissection and transplantation
• Abstracts: The role of nurses in reducing the use of tobacco. 'The big question is whether assistant practitioners will usurp nurses' roles'
• Abstracts: Diabetes and coronary revascularization. Terminal complement blockade with pexelizumab during coronary and artery bypass graft surgery requiring cardiopulmonary bypass

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.